We serve Chemical Name:(6R,7R)-3-methyl-8-oxo-7-[[2-[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid CAS:52231-20-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![(6R,7R)-3-methyl-8-oxo-7-[[2-[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid](https://a.dearchem.com/CAS2/52231-20-6.png)
Chemical Name:(6R,7R)-3-methyl-8-oxo-7-[[2-[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
CAS.NO:52231-20-6
Synonyms:(6r,7r)-3-methyl-8-oxo-7-(2-(p-(1,4,5,6-tetrahydro-2-pyrimidinyl)phenyl)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;Cefrotilo;Cefrotilum;Cefrotil;Cefrotilum [INN-Latin];Cefrotilo [INN-Spanish]
Molecular Formula:C20H22N4O4S
Molecular Weight:414.47800
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:823.6ºC at 760mmHg
Density:1.54g/cm3
Index of Refraction:1.745
PSA:136.40000
Exact Mass:414.13600
LogP:0.82070
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (6r,7r)-3-methyl-8-oxo-7-(2-(p-(1,4,5,6-tetrahydro-2-pyrimidinyl)phenyl)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Cefrotilo [INN-Spanish] physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Cefrotilo Use and application,(6r,7r)-3-methyl-8-oxo-7-(2-(p-(1,4,5,6-tetrahydro-2-pyrimidinyl)phenyl)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid technical grade,usp/ep/jp grade.
Related News: In addition, AstraZeneca is exploring the potential of anifrolumab in a variety of diseases where type I interferon plays a key role, including lupus nephritis, cutaneous lupus erythematosus and myositis. 2-[3-(1,3-dioxolan-2-yl)propyl]-1,3-dioxolane manufacturers Many specialty and biotech organizations are now relying on external service providers to minimize the costs of manufacturing and in-house development required to develop molecules for new drugs and their subsequent clinical trials, explains Saurabh Gurnurkar, executive director, UQUIFA. 3-[(2,3-dimethylphenoxy)methyl]-4-methoxybenzaldehyde suppliers Alexion has been working to push Ultomiris through additional indications ahead of Soliris’ expected loss of exclusivity in 2025. Ethyl N-Boc-2-thiomorpholinecarboxylate vendor & factory.
